Cataract lasers mkt. to hit $2.4 B by 2019, study forecasts

Article

The worldwide market for cataract surgery lasers is forecast to exceed $2.4 billion by 2019, according to a recent study conducted by WinterGreen Research Inc.

Lexington, MA-The worldwide market for cataract surgery lasers is forecast to exceed $2.4 billion by 2019, according to a recent study conducted by WinterGreen Research Inc.

WinterGreen’s published report, Femtosecond Lasers for Cataract Surgery Market Shares, Strategies, and Forecasts, Worldwide, 2013-2018, details how femtosecond laser technology represents a paradigm shift in treating patients with cataracts. The study attributes the driving force behind femtosecond lasers’ market dominance to the ever-increasing aging baby boom population.

Because of the simultaneous change in demographics and the introduction of automated cataract surgery, eyecare professionals face an explosion in demand for their services over the next 20 years. The aging baby boomers and the fact that patients older than 65 consume 10 times the eye care of patients younger than 65 creates unprecedented demand for cataract surgery.

As a result, growing needs and expectations for good vision in all ranges have created significant new market opportunities, expanding demand for multifocal and accommodating IOLs designed to correct presbyopia, aspheric optics that address spherical aberration and make vision sharper, and phakic IOLs allowing treatment of extreme refractive error.

“Superior image quality brings clinical improvement. Patients are thrilled when they can see so much more clearly,” said Susan Eustis, president and co-founder of WinterGreen Research, and lead author of the research team.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.